Episode 5: Interpretation of CDx markers - How do we ensure proper training?

In the fifth episode of Agilent’s “Dialogues in CDx” podcast, we discuss how to ensure proper training for PD-L1 interpretation. Two leaders who are shaping this space discuss why training is important, the best practices, and how it impacts patient care. The first guest in this episode is Dr. Bharat Jasani, Emeritus Professor in Cancer Pathology in the School of Medicine at Cardiff University. Dr. Jasani has been extensively involved in training of more than 1,000 pathologists worldwide in quality assurance and scoring, as well as interpretation of cancer biomarker expression, particularly PD-L1 and HER2. Also joining the conversation is Karin Salomon who has worked for Agilent Technologies in R&D for more than 20 years as a principal microscopy expert. Karin is evaluating thousands of HER2 and PD-L1 stained slides every year and trains pathologists in scoring of various biomarkers through Agilent’s Biomarker Pathologist Training Program in Europe. This podcast series is part of the educational resources supporting the PD-L1 IHC 22C3 pharmDx assay. For access to all episodes plus a wealth of additional PD-L1 education for pathologists, explore Agilent's ⁠⁠⁠CDx Digital Education Portal⁠⁠⁠ today. D0133059 _1.00